Stephen A. Sherwin, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), a $11.4 billion biopharmaceutical company with strong financials and a healthy current ratio of 3.4, sold 13,831 shares of ...

We recently published a list of 10 Small–Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a look at where Travere Therapeutics, Inc.

This article summarizes the most significant insider buys and sells from Thursday, February 13, 2025, for US stocks.

Why are some investors focusing on stocks with smaller market capitalizations? Among some of the reasons are diversification ...